Cost –utility of cardiac contractility modulation in patients with heart failure with reduced ejection fraction in Italy

ConclusionsFor patients with heart failure with reduced ejection fraction, CCM therapy could be cost-effective when taking a lifetime horizon. Further long-term, post-approval clinical studies are needed to verify these results in a real-world context, particularly concerning the effect of CCM therapy on mortality.

Source: ESC Heart Failure - November 9, 2023 Category: Cardiology Authors: Maria Lucia Narducci, Mario Cesare Nurchis, Federico Ballacci, Federica Giordano, Giovanna Elisa Calabr ò, Massimo Massetti, Filippo Crea, Nadia Aspromonte, Gianfranco Damiani Tags: Original Article Source Type: research